APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence in Epidemiology

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Artificial Intelligence in Epidemiology Market Outlook and Growth Opportunities 2026

4 January 2026210 pages

Choose your research edition.

Industry ResearchArtificial Intelligence in Epidemiology Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence in Epidemiology Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence in Epidemiology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence in Epidemiology Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence in Epidemiology Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Artificial Intelligence in Epidemiology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Artificial Intelligence in Epidemiology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Artificial Intelligence in Epidemiology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artificial Intelligence in Epidemiology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Artificial Intelligence in Epidemiology market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Artificial Intelligence in Epidemiology market include Abbott Informatics, AdvancedMD, Agilent Technologies, Allscripts Healthcare, Athenahealth, Autoscribe Informatics, Cerner Corporation, Change Healthcare and Cognizant, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Artificial Intelligence in Epidemiology market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artificial Intelligence in Epidemiology and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artificial Intelligence in Epidemiology revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Artificial Intelligence in Epidemiology market.

Artificial Intelligence in Epidemiology Segment by Company

Abbott Informatics

AdvancedMD

Agilent Technologies

Allscripts Healthcare

Athenahealth

Autoscribe Informatics

Cerner Corporation

Change Healthcare

Cognizant

CPSI

CureMD Healthcare

eClinicalWorks

e-Mds Inc.

Epic Systems

GE Healthcare

Google

Graphcore

Greenway Health

IBM

Intel

InterSystems

Kareo

Medhost

Meditech

Medtronic

Micron Technology

Microsoft

NextGen Healthcare

Nvidia

Optum Inc.

Artificial Intelligence in Epidemiology Segment by Type

Hardware Technology

Software Technology

Artificial Intelligence in Epidemiology Segment by Application

Disease and Syndromic Surveillance

Infection Prediction and Forecasting

Immunization Information Systems

Public Sentiment Analysis

Environmental Impact Analysis

Drug Discovery, Safety, and Risk Analysis

Monitoring Population and Incidence

Knowledge Representation and Mass Notification

Artificial Intelligence in Epidemiology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Artificial Intelligence in Epidemiology status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Artificial Intelligence in Epidemiology key companies, revenue, market share, and recent developments.

3. To split the Artificial Intelligence in Epidemiology breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Artificial Intelligence in Epidemiology market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Artificial Intelligence in Epidemiology significant trends, drivers, influence factors in global and regions.

6. To analyze Artificial Intelligence in Epidemiology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence in Epidemiology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence in Epidemiology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence in Epidemiology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Intelligence in Epidemiology industry.

Chapter 3: Detailed analysis of Artificial Intelligence in Epidemiology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Artificial Intelligence in Epidemiology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Artificial Intelligence in Epidemiology in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Artificial Intelligence in Epidemiology Industry Trends Table 2. Artificial Intelligence in Epidemiology Industry Drivers Table 3. Artificial Intelligence in Epidemiology Industry Opportunities and Challenges Table 4. Artificial Intelligence in Epidemiology Industry Restraints Table 5. Global Artificial Intelligence in Epidemiology Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Artificial Intelligence in Epidemiology Revenue Share by Company (2021-2026) Table 7. Global Artificial Intelligence in Epidemiology Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Artificial Intelligence in Epidemiology Key Company Manufacturing Base & Headquarters Table 9. Global Artificial Intelligence in Epidemiology Company, Product Type & Application Table 10. Global Artificial Intelligence in Epidemiology Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Artificial Intelligence in Epidemiology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Hardware Technology Table 15. Significant Companies of Software Technology Table 16. Global Artificial Intelligence in Epidemiology Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Artificial Intelligence in Epidemiology Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Artificial Intelligence in Epidemiology Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Artificial Intelligence in Epidemiology Sales Value Share by Type (2021-2026) Table 20. Global Artificial Intelligence in Epidemiology Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Disease and Syndromic Surveillance Table 22. Significant Companies of Infection Prediction and Forecasting Table 23. Significant Companies of Immunization Information Systems Table 24. Significant Companies of Public Sentiment Analysis Table 25. Significant Companies of Environmental Impact Analysis Table 26. Significant Companies of Drug Discovery, Safety, and Risk Analysis Table 27. Significant Companies of Monitoring Population and Incidence Table 28. Significant Companies of Knowledge Representation and Mass Notification Table 29. Global Artificial Intelligence in Epidemiology Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Artificial Intelligence in Epidemiology Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Artificial Intelligence in Epidemiology Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Artificial Intelligence in Epidemiology Sales Value Share by Application (2021-2026) Table 33. Global Artificial Intelligence in Epidemiology Sales Value Share by Application (2027-2032) Table 34. Global Artificial Intelligence in Epidemiology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Artificial Intelligence in Epidemiology Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Artificial Intelligence in Epidemiology Sales Value Share by Region (2021-2026) Table 37. Global Artificial Intelligence in Epidemiology Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Artificial Intelligence in Epidemiology Sales Value Share by Region (2027-2032) Table 39. Global Artificial Intelligence in Epidemiology Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Artificial Intelligence in Epidemiology Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Artificial Intelligence in Epidemiology Sales Value Market Share by Country (2021-2026) Table 42. Global Artificial Intelligence in Epidemiology Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Artificial Intelligence in Epidemiology Sales Value Market Share by Country (2027-2032) Table 44. Abbott Informatics Company Information Table 45. Abbott Informatics Business Overview Table 46. Abbott Informatics Artificial Intelligence in Epidemiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Abbott Informatics Artificial Intelligence in Epidemiology Product Portfolio Table 48. Abbott Informatics Recent Development Table 49. AdvancedMD Company Information Table 50. AdvancedMD Business Overview Table 51. AdvancedMD Artificial Intelligence in Epidemiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. AdvancedMD Artificial Intelligence in Epidemiology Product Portfolio Table 53. AdvancedMD Recent Development Table 54. Agilent Technologies Company Information Table 55. Agilent Technologies Business Overview Table 56. Agilent Technologies Artificial Intelligence in Epidemiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Agilent Technologies Artificial Intelligence in Epidemiology Product Portfolio Table 58. Agilent Technologies Recent Development Table 59. Allscripts Healthcare Company Information Table 60. Allscripts Healthcare Business Overview Table 61. Allscripts Healthcare Artificial Intelligence in Epidemiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Allscripts Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 63. Allscripts Healthcare Recent Development Table 64. Athenahealth Company Information Table 65. Athenahealth Business Overview Table 66. Athenahealth Artificial Intelligence in Epidemiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Athenahealth Artificial Intelligence in Epidemiology Product Portfolio Table 68. Athenahealth Recent Development Table 69. Autoscribe Informatics Company Information Table 70. Autoscribe Informatics Business Overview Table 71. Autoscribe Informatics Artificial Intelligence in Epidemiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Autoscribe Informatics Artificial Intelligence in Epidemiology Product Portfolio Table 73. Autoscribe Informatics Recent Development Table 74. Cerner Corporation Company Information Table 75. Cerner Corporation Business Overview Table 76. Cerner Corporation Artificial Intelligence in Epidemiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Cerner Corporation Artificial Intelligence in Epidemiology Product Portfolio Table 78. Cerner Corporation Recent Development Table 79. Change Healthcare Company Information Table 80. Change Healthcare Business Overview Table 81. Change Healthcare Artificial Intelligence in Epidemiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Change Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 83. Change Healthcare Recent Development Table 84. Cognizant Company Information Table 85. Cognizant Business Overview Table 86. Cognizant Artificial Intelligence in Epidemiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Cognizant Artificial Intelligence in Epidemiology Product Portfolio Table 88. Cognizant Recent Development Table 89. CPSI Company Information Table 90. CPSI Business Overview Table 91. CPSI Artificial Intelligence in Epidemiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. CPSI Artificial Intelligence in Epidemiology Product Portfolio Table 93. CPSI Recent Development Table 94. CureMD Healthcare Company Information Table 95. CureMD Healthcare Business Overview Table 96. CureMD Healthcare Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. CureMD Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 98. CureMD Healthcare Recent Development Table 99. eClinicalWorks Company Information Table 100. eClinicalWorks Business Overview Table 101. eClinicalWorks Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. eClinicalWorks Artificial Intelligence in Epidemiology Product Portfolio Table 103. eClinicalWorks Recent Development Table 104. e-Mds Inc. Company Information Table 105. e-Mds Inc. Business Overview Table 106. e-Mds Inc. Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. e-Mds Inc. Artificial Intelligence in Epidemiology Product Portfolio Table 108. e-Mds Inc. Recent Development Table 109. Epic Systems Company Information Table 110. Epic Systems Business Overview Table 111. Epic Systems Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Epic Systems Artificial Intelligence in Epidemiology Product Portfolio Table 113. Epic Systems Recent Development Table 114. GE Healthcare Company Information Table 115. GE Healthcare Business Overview Table 116. GE Healthcare Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. GE Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 118. GE Healthcare Recent Development Table 119. Google Company Information Table 120. Google Business Overview Table 121. Google Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Google Artificial Intelligence in Epidemiology Product Portfolio Table 123. Google Recent Development Table 124. Graphcore Company Information Table 125. Graphcore Business Overview Table 126. Graphcore Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Graphcore Artificial Intelligence in Epidemiology Product Portfolio Table 128. Graphcore Recent Development Table 129. Greenway Health Company Information Table 130. Greenway Health Business Overview Table 131. Greenway Health Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Greenway Health Artificial Intelligence in Epidemiology Product Portfolio Table 133. Greenway Health Recent Development Table 134. IBM Company Information Table 135. IBM Business Overview Table 136. IBM Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. IBM Artificial Intelligence in Epidemiology Product Portfolio Table 138. IBM Recent Development Table 139. Intel Company Information Table 140. Intel Business Overview Table 141. Intel Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. Intel Artificial Intelligence in Epidemiology Product Portfolio Table 143. Intel Recent Development Table 144. InterSystems Company Information Table 145. InterSystems Business Overview Table 146. InterSystems Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. InterSystems Artificial Intelligence in Epidemiology Product Portfolio Table 148. InterSystems Recent Development Table 149. Kareo Company Information Table 150. Kareo Business Overview Table 151. Kareo Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. Kareo Artificial Intelligence in Epidemiology Product Portfolio Table 153. Kareo Recent Development Table 154. Medhost Company Information Table 155. Medhost Business Overview Table 156. Medhost Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. Medhost Artificial Intelligence in Epidemiology Product Portfolio Table 158. Medhost Recent Development Table 159. Meditech Company Information Table 160. Meditech Business Overview Table 161. Meditech Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. Meditech Artificial Intelligence in Epidemiology Product Portfolio Table 163. Meditech Recent Development Table 164. Medtronic Company Information Table 165. Medtronic Business Overview Table 166. Medtronic Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 167. Medtronic Artificial Intelligence in Epidemiology Product Portfolio Table 168. Medtronic Recent Development Table 169. Micron Technology Company Information Table 170. Micron Technology Business Overview Table 171. Micron Technology Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 172. Micron Technology Artificial Intelligence in Epidemiology Product Portfolio Table 173. Micron Technology Recent Development Table 174. Microsoft Company Information Table 175. Microsoft Business Overview Table 176. Microsoft Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 177. Microsoft Artificial Intelligence in Epidemiology Product Portfolio Table 178. Microsoft Recent Development Table 179. NextGen Healthcare Company Information Table 180. NextGen Healthcare Business Overview Table 181. NextGen Healthcare Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 182. NextGen Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 183. NextGen Healthcare Recent Development Table 184. Nvidia Company Information Table 185. Nvidia Business Overview Table 186. Nvidia Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 187. Nvidia Artificial Intelligence in Epidemiology Product Portfolio Table 188. Nvidia Recent Development Table 189. Optum Inc. Company Information Table 190. Optum Inc. Business Overview Table 191. Optum Inc. Artificial Intelligence in Epidemiology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 192. Optum Inc. Artificial Intelligence in Epidemiology Product Portfolio Table 193. Optum Inc. Recent Development Table 194. Research Programs/Design for This Report Table 195. Authors List of This Report Table 196. Secondary Sources Table 197. Primary Sources List of Figures Figure 1. Artificial Intelligence in Epidemiology Product Image Figure 2. Global Artificial Intelligence in Epidemiology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Intelligence in Epidemiology Market Size (2021-2032) & (US$ Million) Figure 4. Global Artificial Intelligence in Epidemiology Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Hardware Technology Image Figure 8. Software Technology Image Figure 9. Global Artificial Intelligence in Epidemiology Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Artificial Intelligence in Epidemiology Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Artificial Intelligence in Epidemiology Sales Value Share by Type (2021-2032) Figure 12. Disease and Syndromic Surveillance Image Figure 13. Infection Prediction and Forecasting Image Figure 14. Immunization Information Systems Image Figure 15. Public Sentiment Analysis Image Figure 16. Environmental Impact Analysis Image Figure 17. Drug Discovery, Safety, and Risk Analysis Image Figure 18. Monitoring Population and Incidence Image Figure 19. Knowledge Representation and Mass Notification Image Figure 20. Global Artificial Intelligence in Epidemiology Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Artificial Intelligence in Epidemiology Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Artificial Intelligence in Epidemiology Sales Value Share by Application (2021-2032) Figure 23. Global Artificial Intelligence in Epidemiology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Artificial Intelligence in Epidemiology Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Artificial Intelligence in Epidemiology Sales Value (2021-2032) & (US$ Million) Figure 26. North America Artificial Intelligence in Epidemiology Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Artificial Intelligence in Epidemiology Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Artificial Intelligence in Epidemiology Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Artificial Intelligence in Epidemiology Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Artificial Intelligence in Epidemiology Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Artificial Intelligence in Epidemiology Sales Value (2021-2032) & (US$ Million) Figure 32. South America Artificial Intelligence in Epidemiology Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Artificial Intelligence in Epidemiology Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Artificial Intelligence in Epidemiology Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Hardware Technology
  • Software Technology
Applications
  • Disease and Syndromic Surveillance
  • Infection Prediction and Forecasting
  • Immunization Information Systems
  • Public Sentiment Analysis
  • Environmental Impact Analysis
  • Drug Discovery, Safety, and Risk Analysis
  • Monitoring Population and Incidence
  • Knowledge Representation and Mass Notification
Companies covered
  • Abbott Informatics
  • AdvancedMD
  • Agilent Technologies
  • Allscripts Healthcare
  • Athenahealth
  • Autoscribe Informatics
  • Cerner Corporation
  • Change Healthcare
  • Cognizant
  • CPSI
  • CureMD Healthcare
  • eClinicalWorks
  • e-Mds Inc.
  • Epic Systems
  • GE Healthcare
  • Google
  • Graphcore
  • Greenway Health
  • IBM
  • Intel
  • InterSystems
  • Kareo
  • Medhost
  • Meditech
  • Medtronic
  • Micron Technology
  • Microsoft
  • NextGen Healthcare
  • Nvidia
  • Optum Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Artificial Intelligence in Epidemiology Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Artificial Intelligence in Epidemiology Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Artificial Intelligence in Epidemiology Market Dynamics
  1. 2.1 Artificial Intelligence in Epidemiology Industry Trends
  2. 2.2 Artificial Intelligence in Epidemiology Industry Drivers
  3. 2.3 Artificial Intelligence in Epidemiology Industry Opportunities and Challenges
  4. 2.4 Artificial Intelligence in Epidemiology Industry Restraints
3 Artificial Intelligence in Epidemiology Market by Company
  1. 3.1 Global Artificial Intelligence in Epidemiology Company Revenue Ranking in 2025
  2. 3.2 Global Artificial Intelligence in Epidemiology Revenue by Company (2021-2026)
  3. 3.3 Global Artificial Intelligence in Epidemiology Company Ranking (2024-2026)
  4. 3.4 Global Artificial Intelligence in Epidemiology Company Manufacturing Base and Headquarters
  5. 3.5 Global Artificial Intelligence in Epidemiology Company Product Type and Application
  6. 3.6 Global Artificial Intelligence in Epidemiology Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Artificial Intelligence in Epidemiology Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Artificial Intelligence in Epidemiology Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Artificial Intelligence in Epidemiology Market by Type
  1. 4.1 Artificial Intelligence in Epidemiology Type Introduction
  2. 4.1.1 Hardware Technology
  3. 4.1.2 Software Technology
  4. 4.2 Global Artificial Intelligence in Epidemiology Sales Value by Type
  5. 4.2.1 Global Artificial Intelligence in Epidemiology Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Artificial Intelligence in Epidemiology Sales Value by Type (2021-2032)
  7. 4.2.3 Global Artificial Intelligence in Epidemiology Sales Value Share by Type (2021-2032)
5 Artificial Intelligence in Epidemiology Market by Application
  1. 5.1 Artificial Intelligence in Epidemiology Application Introduction
  2. 5.1.1 Disease and Syndromic Surveillance
  3. 5.1.2 Infection Prediction and Forecasting
  4. 5.1.3 Immunization Information Systems
  5. 5.1.4 Public Sentiment Analysis
  6. 5.1.5 Environmental Impact Analysis
  7. 5.1.6 Drug Discovery, Safety, and Risk Analysis
  8. 5.1.7 Monitoring Population and Incidence
  9. 5.1.8 Knowledge Representation and Mass Notification
  10. 5.2 Global Artificial Intelligence in Epidemiology Sales Value by Application
  11. 5.2.1 Global Artificial Intelligence in Epidemiology Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.2.2 Global Artificial Intelligence in Epidemiology Sales Value by Application (2021-2032)
  13. 5.2.3 Global Artificial Intelligence in Epidemiology Sales Value Share by Application (2021-2032)
6 Artificial Intelligence in Epidemiology Regional Value Analysis
  1. 6.1 Global Artificial Intelligence in Epidemiology Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artificial Intelligence in Epidemiology Sales Value by Region (2021-2032)
  3. 6.2.1 Global Artificial Intelligence in Epidemiology Sales Value by Region: 2021-2026
  4. 6.2.2 Global Artificial Intelligence in Epidemiology Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Artificial Intelligence in Epidemiology Sales Value (2021-2032)
  7. 6.3.2 North America Artificial Intelligence in Epidemiology Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Artificial Intelligence in Epidemiology Sales Value (2021-2032)
  10. 6.4.2 Europe Artificial Intelligence in Epidemiology Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Artificial Intelligence in Epidemiology Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Artificial Intelligence in Epidemiology Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Artificial Intelligence in Epidemiology Sales Value (2021-2032)
  16. 6.6.2 South America Artificial Intelligence in Epidemiology Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Artificial Intelligence in Epidemiology Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Artificial Intelligence in Epidemiology Sales Value Share by Country, 2025 VS 2032
7 Artificial Intelligence in Epidemiology Country-level Value Analysis
  1. 7.1 Global Artificial Intelligence in Epidemiology Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Artificial Intelligence in Epidemiology Sales Value by Country (2021-2032)
  3. 7.2.1 Global Artificial Intelligence in Epidemiology Sales Value by Country (2021-2026)
  4. 7.2.2 Global Artificial Intelligence in Epidemiology Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Artificial Intelligence in Epidemiology Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Artificial Intelligence in Epidemiology Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Artificial Intelligence in Epidemiology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Informatics
  2. 8.1.1 Abbott Informatics Company Information
  3. 8.1.2 Abbott Informatics Business Overview
  4. 8.1.3 Abbott Informatics Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Informatics Artificial Intelligence in Epidemiology Product Portfolio
  6. 8.1.5 Abbott Informatics Recent Developments
  7. 8.2 AdvancedMD
  8. 8.2.1 AdvancedMD Company Information
  9. 8.2.2 AdvancedMD Business Overview
  10. 8.2.3 AdvancedMD Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AdvancedMD Artificial Intelligence in Epidemiology Product Portfolio
  12. 8.2.5 AdvancedMD Recent Developments
  13. 8.3 Agilent Technologies
  14. 8.3.1 Agilent Technologies Company Information
  15. 8.3.2 Agilent Technologies Business Overview
  16. 8.3.3 Agilent Technologies Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Agilent Technologies Artificial Intelligence in Epidemiology Product Portfolio
  18. 8.3.5 Agilent Technologies Recent Developments
  19. 8.4 Allscripts Healthcare
  20. 8.4.1 Allscripts Healthcare Company Information
  21. 8.4.2 Allscripts Healthcare Business Overview
  22. 8.4.3 Allscripts Healthcare Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Allscripts Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  24. 8.4.5 Allscripts Healthcare Recent Developments
  25. 8.5 Athenahealth
  26. 8.5.1 Athenahealth Company Information
  27. 8.5.2 Athenahealth Business Overview
  28. 8.5.3 Athenahealth Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Athenahealth Artificial Intelligence in Epidemiology Product Portfolio
  30. 8.5.5 Athenahealth Recent Developments
  31. 8.6 Autoscribe Informatics
  32. 8.6.1 Autoscribe Informatics Company Information
  33. 8.6.2 Autoscribe Informatics Business Overview
  34. 8.6.3 Autoscribe Informatics Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Autoscribe Informatics Artificial Intelligence in Epidemiology Product Portfolio
  36. 8.6.5 Autoscribe Informatics Recent Developments
  37. 8.7 Cerner Corporation
  38. 8.7.1 Cerner Corporation Company Information
  39. 8.7.2 Cerner Corporation Business Overview
  40. 8.7.3 Cerner Corporation Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cerner Corporation Artificial Intelligence in Epidemiology Product Portfolio
  42. 8.7.5 Cerner Corporation Recent Developments
  43. 8.8 Change Healthcare
  44. 8.8.1 Change Healthcare Company Information
  45. 8.8.2 Change Healthcare Business Overview
  46. 8.8.3 Change Healthcare Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Change Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  48. 8.8.5 Change Healthcare Recent Developments
  49. 8.9 Cognizant
  50. 8.9.1 Cognizant Company Information
  51. 8.9.2 Cognizant Business Overview
  52. 8.9.3 Cognizant Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cognizant Artificial Intelligence in Epidemiology Product Portfolio
  54. 8.9.5 Cognizant Recent Developments
  55. 8.10 CPSI
  56. 8.10.1 CPSI Company Information
  57. 8.10.2 CPSI Business Overview
  58. 8.10.3 CPSI Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CPSI Artificial Intelligence in Epidemiology Product Portfolio
  60. 8.10.5 CPSI Recent Developments
  61. 8.11 CureMD Healthcare
  62. 8.11.1 CureMD Healthcare Company Information
  63. 8.11.2 CureMD Healthcare Business Overview
  64. 8.11.3 CureMD Healthcare Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CureMD Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  66. 8.11.5 CureMD Healthcare Recent Developments
  67. 8.12 eClinicalWorks
  68. 8.12.1 eClinicalWorks Company Information
  69. 8.12.2 eClinicalWorks Business Overview
  70. 8.12.3 eClinicalWorks Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  71. 8.12.4 eClinicalWorks Artificial Intelligence in Epidemiology Product Portfolio
  72. 8.12.5 eClinicalWorks Recent Developments
  73. 8.13 e-Mds Inc.
  74. 8.13.1 e-Mds Inc. Company Information
  75. 8.13.2 e-Mds Inc. Business Overview
  76. 8.13.3 e-Mds Inc. Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  77. 8.13.4 e-Mds Inc. Artificial Intelligence in Epidemiology Product Portfolio
  78. 8.13.5 e-Mds Inc. Recent Developments
  79. 8.14 Epic Systems
  80. 8.14.1 Epic Systems Company Information
  81. 8.14.2 Epic Systems Business Overview
  82. 8.14.3 Epic Systems Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Epic Systems Artificial Intelligence in Epidemiology Product Portfolio
  84. 8.14.5 Epic Systems Recent Developments
  85. 8.15 GE Healthcare
  86. 8.15.1 GE Healthcare Company Information
  87. 8.15.2 GE Healthcare Business Overview
  88. 8.15.3 GE Healthcare Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  89. 8.15.4 GE Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  90. 8.15.5 GE Healthcare Recent Developments
  91. 8.16 Google
  92. 8.16.1 Google Company Information
  93. 8.16.2 Google Business Overview
  94. 8.16.3 Google Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Google Artificial Intelligence in Epidemiology Product Portfolio
  96. 8.16.5 Google Recent Developments
  97. 8.17 Graphcore
  98. 8.17.1 Graphcore Company Information
  99. 8.17.2 Graphcore Business Overview
  100. 8.17.3 Graphcore Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Graphcore Artificial Intelligence in Epidemiology Product Portfolio
  102. 8.17.5 Graphcore Recent Developments
  103. 8.18 Greenway Health
  104. 8.18.1 Greenway Health Company Information
  105. 8.18.2 Greenway Health Business Overview
  106. 8.18.3 Greenway Health Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Greenway Health Artificial Intelligence in Epidemiology Product Portfolio
  108. 8.18.5 Greenway Health Recent Developments
  109. 8.19 IBM
  110. 8.19.1 IBM Company Information
  111. 8.19.2 IBM Business Overview
  112. 8.19.3 IBM Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  113. 8.19.4 IBM Artificial Intelligence in Epidemiology Product Portfolio
  114. 8.19.5 IBM Recent Developments
  115. 8.20 Intel
  116. 8.20.1 Intel Company Information
  117. 8.20.2 Intel Business Overview
  118. 8.20.3 Intel Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Intel Artificial Intelligence in Epidemiology Product Portfolio
  120. 8.20.5 Intel Recent Developments
  121. 8.21 InterSystems
  122. 8.21.1 InterSystems Company Information
  123. 8.21.2 InterSystems Business Overview
  124. 8.21.3 InterSystems Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  125. 8.21.4 InterSystems Artificial Intelligence in Epidemiology Product Portfolio
  126. 8.21.5 InterSystems Recent Developments
  127. 8.22 Kareo
  128. 8.22.1 Kareo Company Information
  129. 8.22.2 Kareo Business Overview
  130. 8.22.3 Kareo Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Kareo Artificial Intelligence in Epidemiology Product Portfolio
  132. 8.22.5 Kareo Recent Developments
  133. 8.23 Medhost
  134. 8.23.1 Medhost Company Information
  135. 8.23.2 Medhost Business Overview
  136. 8.23.3 Medhost Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Medhost Artificial Intelligence in Epidemiology Product Portfolio
  138. 8.23.5 Medhost Recent Developments
  139. 8.24 Meditech
  140. 8.24.1 Meditech Company Information
  141. 8.24.2 Meditech Business Overview
  142. 8.24.3 Meditech Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Meditech Artificial Intelligence in Epidemiology Product Portfolio
  144. 8.24.5 Meditech Recent Developments
  145. 8.25 Medtronic
  146. 8.25.1 Medtronic Company Information
  147. 8.25.2 Medtronic Business Overview
  148. 8.25.3 Medtronic Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Medtronic Artificial Intelligence in Epidemiology Product Portfolio
  150. 8.25.5 Medtronic Recent Developments
  151. 8.26 Micron Technology
  152. 8.26.1 Micron Technology Company Information
  153. 8.26.2 Micron Technology Business Overview
  154. 8.26.3 Micron Technology Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Micron Technology Artificial Intelligence in Epidemiology Product Portfolio
  156. 8.26.5 Micron Technology Recent Developments
  157. 8.27 Microsoft
  158. 8.27.1 Microsoft Company Information
  159. 8.27.2 Microsoft Business Overview
  160. 8.27.3 Microsoft Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Microsoft Artificial Intelligence in Epidemiology Product Portfolio
  162. 8.27.5 Microsoft Recent Developments
  163. 8.28 NextGen Healthcare
  164. 8.28.1 NextGen Healthcare Company Information
  165. 8.28.2 NextGen Healthcare Business Overview
  166. 8.28.3 NextGen Healthcare Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  167. 8.28.4 NextGen Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  168. 8.28.5 NextGen Healthcare Recent Developments
  169. 8.29 Nvidia
  170. 8.29.1 Nvidia Company Information
  171. 8.29.2 Nvidia Business Overview
  172. 8.29.3 Nvidia Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Nvidia Artificial Intelligence in Epidemiology Product Portfolio
  174. 8.29.5 Nvidia Recent Developments
  175. 8.30 Optum Inc.
  176. 8.30.1 Optum Inc. Company Information
  177. 8.30.2 Optum Inc. Business Overview
  178. 8.30.3 Optum Inc. Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Optum Inc. Artificial Intelligence in Epidemiology Product Portfolio
  180. 8.30.5 Optum Inc. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst